News and innovation - February 12, 2024
Best practices for phase 1 investigational drugs trials
Before pharmaceutical products are released onto the market, they undergo extensive screening as an investigational drug (IND, or investigational new…
Best practices for phase 1 investigational drugs trials
Before pharmaceutical products are released onto the market, they undergo extensive screening as an investigational drug (IND, or investigational new…
Key insights on recent amendments to EU-MDR
The European Medical Device Regulation (EU-MDR) 2017/745 has brought many changes to the medical device industry and product availability. Thanks…
“Complications of IV catheter therapy are simply the result of one complex and highly variable mechanical system—IV catheter equipment design,...
PICC line or port catheter: Which one for cancer patients?
It can be challenging knowing when to insert a peripherally inserted central catheter (PICC line) or port catheter into patients…
Quality control of prefilled flush syringes: key considerations
Before delving into the quality control of prefilled flush syringes, which are an integral part of vascular access management (VAM),…
Antibiotics shortages in Europe: what you need to know
“A new approach is needed to better tackle medicines shortages in the European Health Union,” the European Commission said in…
Safe connections webinar: open vs closed IV access
How can we define safe connections? Connections are critical junctures and/or points of access along intravenous (IV) lines. Microorganisms may…
Spanish vascular access team refines device selection algorithm
The Vall D’Hebron Hospital in Barcelona, Spain treats over 1.2 million patients per year, with 1,100 beds and a team…
Become
...